Precigen (PGEN) EBITDA Margin (QoQ) (2012 - 2026)
Precigen (PGEN) EBITDA Margin (QoQ) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
44,883.00 |
| Jun 30, 2025 |
-9.17 Mn |
| Mar 31, 2025 |
28,569.00 |
| Dec 31, 2024 |
42,908.00 |
| Sep 30, 2024 |
664,049.00 |
| Jun 30, 2024 |
864,814.00 |
| Mar 31, 2024 |
-1.49 Mn |
| Dec 31, 2023 |
209.09 Mn |
| Sep 30, 2023 |
-209.25 Mn |
| Jun 30, 2023 |
605,105.00 |
| Mar 31, 2023 |
-739,862.00 |
| Dec 31, 2022 |
58,741.00 |
| Sep 30, 2022 |
39,494.00 |
| Jun 30, 2022 |
-42,819.00 |
| Mar 31, 2022 |
-61,616.00 |
| Dec 31, 2021 |
86,029.00 |
| Sep 30, 2021 |
4,122.00 |
| Jun 30, 2021 |
-61,502.00 |
| Mar 31, 2021 |
11,272.00 |
| Dec 31, 2020 |
-9,664.00 |
